Find therapies in clinical trials near you – page 493

Study of Cannabidiol for Treatment of Recurrent Pericarditis in Affected Patients

Study of Cannabidiol for Treatment of Recurrent Pericarditis in Affected Patients

Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

Safety, Tolerability, PK and PD of Nipocalimab (JNJ-80202135) Subcutaneous Injection via Syringe or Prefilled Autoinjector in Healthy Volunteers

A study to compare how hydrochlorothiazide tablets work in healthy volunteers

A study to evaluate how food affects the absorption of cytisinicline in healthy adult smokers

Pharmacokinetics of Nicorandil 40 mg Extended‑Release Capsules in Healthy Volunteers Under Fasting and Fed Conditions

A study to examine how the body processes and removes DC-806 in healthy male volunteers

A study to examine how the body processes and removes DC-806 in healthy male volunteers

A study to compare how perampanel is absorbed in healthy adult men and women.

Relative bioavailability of BI 685509 tablets and the impact of food and esomeprazole on BI 685509 in healthy male volunteers

Relative bioavailability of BI 685509 tablets and the impact of food and esomeprazole on BI 685509 in healthy male volunteers

Effect of moderate or severe liver impairment on the pharmacokinetics, safety and tolerability of camizestrant in post‑menopausal women

Effect of moderate or severe liver impairment on the pharmacokinetics, safety and tolerability of camizestrant in post‑menopausal women

Phase 1 safety and dose-finding study of NG-350A plus pembrolizumab in patients with metastatic cancer

Phase 1 safety and dose-finding study of NG-350A plus pembrolizumab in patients with metastatic cancer

A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy

A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy